
51 - 200 funcionários
Fundada em 2005
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Capricor Therapeutics, Inc. é uma empresa de biotecnologia em estágio clínico que desenvolve terapias baseadas em células e exossomos, focada em medicina de precisão para distrofia muscular de Duchenne e outras doenças graves. A empresa avança com células derivadas de cardiosferas alogênicas (CDCs) e plataformas de exossomos em um pipeline de múltiplas etapas, incluindo terapia celular investigativa (deramiocel) e abordagens para carregar oligonucleotídeos terapêuticos em exossomos. A Capricor enfatiza o desenvolvimento centrado no paciente, pesquisa translacional e parcerias estratégicas para trazer novos medicamentos biológicos aos pacientes.
🕒 Junho 2
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $250.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
👻 Score fantasma 14%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2005
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Capricor Therapeutics, Inc. é uma empresa de biotecnologia em estágio clínico que desenvolve terapias baseadas em células e exossomos, focada em medicina de precisão para distrofia muscular de Duchenne e outras doenças graves. A empresa avança com células derivadas de cardiosferas alogênicas (CDCs) e plataformas de exossomos em um pipeline de múltiplas etapas, incluindo terapia celular investigativa (deramiocel) e abordagens para carregar oligonucleotídeos terapêuticos em exossomos. A Capricor enfatiza o desenvolvimento centrado no paciente, pesquisa translacional e parcerias estratégicas para trazer novos medicamentos biológicos aos pacientes.
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.**• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.**• Support advisory boards, scientific symposia, and KOL-led research initiatives.**• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.**• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.**• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.**• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.**• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.**• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.**• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.**• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.**• Perform other duties as may be assigned from time to time.
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).**• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.**• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.**• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.**• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.**• Self-directed execution and the ability to operate independently in a field-based environment.
• Collaborative environment for professional growth and innovation
Candidatar-se🕒 Junho 2
Legal transactions director leading M&A, investments, and strategic partnerships for Ciena, a high-speed connectivity company. Driving deal execution, due diligence, negotiation, and post-close integration.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $181.000 - $269.100 / ano
💰 Series C em 1995-12
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 1
Regional Director responsible for Medical Informatics sales in the Pacific Northwest region. Achieving bookings and revenue objectives through strategic selling in a healthcare technology company.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🗣️🇪🇸 Espanhol obrigatório
🕒 Junho 1
Director of Consulting Services at Zaviant, leading delivery in data security, privacy, and risk management. Focusing on operational excellence and client satisfaction in a boutique consulting firm.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Maio 31
Division Contract Director overseeing DOJ's MEGA 6 automated litigation support program. Responsible for contact coordination with government and managing division operations in a remote work setting.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Maio 31
Senior manager coordinating DOJ-Wide Contract Director activities supporting ITC Federal's work for the U.S. Department of Justice under the anticipated MEGA 6 program.
🗣️🇺🇸🇬🇧 Inglês obrigatório